Geneos Wealth Management’s First Trust Latin America AlphaDEX Fund FLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,078
Closed -$17K 2209
2022
Q2
$17K Buy
1,078
+32
+3% +$608 ﹤0.01% 1747
2022
Q1
$21K Buy
1,046
+1
+0.1% +$18 ﹤0.01% 1778
2021
Q4
$18K Buy
1,045
+24
+2% +$415 ﹤0.01% 1932
2021
Q3
$18K Buy
1,021
+10
+1% +$192 ﹤0.01% 1966
2021
Q2
$20K Buy
1,011
+9
+0.9% +$176 ﹤0.01% 1918
2021
Q1
$19K Hold
1,002
﹤0.01% 2106
2020
Q4
$18K Buy
1,002
+7
+0.7% +$120 ﹤0.01% 1963
2020
Q3
$14K Buy
995
+11
+1% +$173 ﹤0.01% 1822
2020
Q2
$14K Buy
984
+7
+0.7% +$95 ﹤0.01% 1770
2020
Q1
$12K Buy
977
+2
+0.2% +$39 ﹤0.01% 1722
2019
Q4
$22K Buy
+975
New +$20.3K ﹤0.01% 1635
2018
Q2
Sell
-3,300
Closed -$73K 2281
2018
Q1
$73K Hold
3,300
0.01% 854
2017
Q4
$67K Buy
+3,300
New +$70.6K 0.01% 885

Other funds holding FLN

Geneos Wealth Management's FLN Position: Q3 2022 in Review

Geneos Wealth Management sold out of First Trust Latin America AlphaDEX Fund (FLN) in Q3 2022, closing a stake of 1,078 shares — an estimated $17K sold.

Geneos Wealth Management first reported a position in FLN in Q4 2017 and held it in 13 quarters. The position peaked at $73K in Q1 2018. 22 funds tracked by Wall St. Rank hold FLN as of Q3 2022.

  • Geneos Wealth Management reported no remaining First Trust Latin America AlphaDEX Fund position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 1,078 First Trust Latin America AlphaDEX Fund shares in Q3 2022, an estimated $17K.
  • Geneos Wealth Management first reported a position in First Trust Latin America AlphaDEX Fund in Q4 2017 and held it in 13 quarters.
  • Geneos Wealth Management's First Trust Latin America AlphaDEX Fund position peaked at $73K in Q1 2018.
  • 22 funds tracked by Wall St. Rank held First Trust Latin America AlphaDEX Fund as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.